Predict your next investment

Infosys Science Foundation company logo
BUSINESS PRODUCTS & SERVICES
infosys-science-foundation.com

See what CB Insights has to offer

Stage

Other Investors | Alive

Revenue

$0000 

About Infosys Science Foundation

Infosys Science Foundation is a not-for-profit trust that instituted the Infosys prize, an annual award, to honor outstanding achievements of researchers and scientists. It is based in Bangalore, India.

Infosys Science Foundation Headquarter Location

Plot No, 44, Hosur Rd Konappana Agrahara, Electronic City

Bangalore,

India

Latest Infosys Science Foundation News

What will drive RIL’s Q3 earnings?-Business Journal

Jan 20, 2022

As benchmark indices head lower due to rising global headwinds, stock-specific opportunity amid Q3 results is helping investors trim losses. So far, the December quarter results have, largely, been positive for the Street with majority of the companies, including Infosys, TCS, HDFC Bank, Bajaj Finance and Metro Brands posting better-than-expected earnings growth. And now, all eyes will be on the earnings report card of index major Reliance Industries, which is scheduled to report its results, tomorrow. Global brokerage Morgan Stanley expects the two Rs – Refining and Retail – to drive the earnings in Q3 with demand and margin surprises likely in both these segments. For the quarter, the brokerage projects a 9% quarter-on-quarter earnings growth, driven mostly by improvement in gasoline and diesel margins. This will be further supported by retail demand in jewellery, electronics and grocery, for which RIL has already reported positive surprises. Overall, the brokerage expects consolidated EBITDA to rise by 8.5% QoQ and 28.5% YoY at Rs 27,722.6 crore. This would be driven by oil to chemicals EBITDA growth of 10% QoQ; telecom growth of 2% QoQ, and retail growth of 35% YoY. Back home, analysts at Emkay Global peg EBITDA growth at 37% YoY and 14% QoQ, while net profit is seen at Rs 16,138 crore, up 23% YoY and 18% QoQ. On a standalone basis, analysts expect RIL’s EBITDA to increase anywhere between 12-15%. Standalone net profit, on the other hand, is seen at Rs 9,906.6 crore, up 13% YoY and over 7% QoQ. The stock of Mukesh Ambani-led company has advanced over 6% year-to-date on the bourses, and analysts expect it to rise another 17%, up to Rs 2,955 apiece, over the next one year. This will be triggered by a combination of higher chemical margins, details on the new energy vertical, and new partnerships in key segments. As regards Thursday’s session, global headwinds and weekly F&O expiry will likely keep the indices choppy through the day. The frontline Sensex index has tumbled over 1,200 points in 2 days and stands at 60,099 level. The Nifty50, meanwhile, has broken below the 18,000-mark and is at 17,938. On the earnings front, over 40 companies, including Asian Paints, Bajaj Finserv, Biocon and HUL are scheduled to report their results today. Among the lot, Hindustan Unilever is likely to clock year-on-year revenue growth of 9-12 per cent in on account of price hikes taken in recent quarters. Analysts, however, expect its volume growth to be flat. Moreover, analysts expect nearly 200 basis points YoY fall in the company’s gross margins due to high commodity inflation. Stock-specific action, initial public offer of AGS Transact Technologies, and news flow around the Omicron variant of Covid-19 will be the other key triggers. Watch video Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request. As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed. Digital Editor

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Infosys Science Foundation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Infosys Science Foundation Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.